Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (171-180 of 557) with videos related to

Pageof 56
Sort By:
The Lancet. Haematology|December 28, 2020
The state of haematopoietic cells transplantation in Latin AmericaGregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman, et al.
Blood Reviews|May 22, 2019
Cellular therapy for acute myeloid Leukemia - Current status and future prospectsPanupong Hansrivijit, Robert Peter Gale, John Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2023
Zanubrutinib in Waldenström MacroglobulinemiaYuan-Bin Song, Jing-Bo Xu, Robert Peter Gale, et al.
Leukemia|August 20, 2021
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, et al.
Bone Marrow Transplantation|November 1, 2019
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantationMegan Othus, Robert Peter Gale, Christopher S Hourigan, et al.
Leukemia|December 5, 2024
Is there really an accelerated phase of chronic myeloid leukaemia at presentation?Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, et al.
Medicine|November 27, 2019
Variables associated with patient-reported symptoms in persons with chronic phase chronic myeloid leukemia receiving tyrosine kinase inhibitor therapyLu Yu, Xiaojun Huang, Robert Peter Gale, et al.
Clinical Transplants|June 24, 2011
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo C Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Critical Reviews in Oncology/Hematology|March 4, 2024
Immune therapies of B-cell acute lymphoblastic leukaemia in children and adultsDavid Kegyes, Gabriel Ghiaur, Anamaria Bancos, et al.
Bone Marrow Transplantation|July 20, 2021
Professor Anton Hagenbeek 1948-2021: Father of MRD and lymphoma expertBob Löwenberg, Marie José Kersten, Robert Peter Gale, et al.
Pageof 56

Showing results (171-180 of 557) with videos related to

Sort By:
Pageof 56
The Lancet. Haematology|December 28, 2020
The state of haematopoietic cells transplantation in Latin AmericaGregorio Jaimovich, Robert Peter Gale, Ignacio Hanesman, et al.
Blood Reviews|May 22, 2019
Cellular therapy for acute myeloid Leukemia - Current status and future prospectsPanupong Hansrivijit, Robert Peter Gale, John Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2023
Zanubrutinib in Waldenström MacroglobulinemiaYuan-Bin Song, Jing-Bo Xu, Robert Peter Gale, et al.
Leukemia|August 20, 2021
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, et al.
Bone Marrow Transplantation|November 1, 2019
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantationMegan Othus, Robert Peter Gale, Christopher S Hourigan, et al.
Leukemia|December 5, 2024
Is there really an accelerated phase of chronic myeloid leukaemia at presentation?Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, et al.
Medicine|November 27, 2019
Variables associated with patient-reported symptoms in persons with chronic phase chronic myeloid leukemia receiving tyrosine kinase inhibitor therapyLu Yu, Xiaojun Huang, Robert Peter Gale, et al.
Clinical Transplants|June 24, 2011
2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo C Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Critical Reviews in Oncology/Hematology|March 4, 2024
Immune therapies of B-cell acute lymphoblastic leukaemia in children and adultsDavid Kegyes, Gabriel Ghiaur, Anamaria Bancos, et al.
Bone Marrow Transplantation|July 20, 2021
Professor Anton Hagenbeek 1948-2021: Father of MRD and lymphoma expertBob Löwenberg, Marie José Kersten, Robert Peter Gale, et al.
Pageof 56